# Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn

> **NCT01785784** · PHASE4 · COMPLETED · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 2510 (actual)

## Conditions studied

- Deep Partial Thickness Burn

## Interventions

- **DRUG:** rhGM-CSF Gel

## Key facts

- **NCT ID:** NCT01785784
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-04
- **Final completion:** 2012-07
- **Target enrollment:** 2510 (ACTUAL)
- **Last updated:** 2013-02-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01785784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01785784, "Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01785784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*